Please Wait
Applying Filters...
menu
    • menu
    LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-11-03

    Virtual Booth

    An Enquiry

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Jai Radhe Sales is your partner for all your sourcing needs.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    An Enquiry

    Menu

    Valbenazine Tosylate

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 5,524Xls

    Filters

    clear-filterReset all filters
    2D Structure
    Also known as: Valbenazine ditosylate, 1639208-54-0, Valbenazine tosilate, Valbenazine (tosylate), Nbi-98854 ditosylate, Valbenazine tosylate [usan]
    Molecular Formula
    C38H54N2O10S2
    Molecular Weight
    763.0  g/mol
    InChI Key
    BXGKAGLZHGYAMW-TZYFFPFWSA-N
    FDA UNII
    5SML1T733B
    1 2D Structure

    2D Structure

    2 Identification
    2.1 Computed Descriptors
    2.1.1 IUPAC Name
    [(2R,3R,11bR)-9,10-dimethoxy-3-(2-methylpropyl)-2,3,4,6,7,11b-hexahydro-1H-benzo[a]quinolizin-2-yl] (2S)-2-amino-3-methylbutanoate;4-methylbenzenesulfonic acid
    2.1.2 InChI
    InChI=1S/C24H38N2O4.2C7H8O3S/c1-14(2)9-17-13-26-8-7-16-10-21(28-5)22(29-6)11-18(16)19(26)12-20(17)30-24(27)23(25)15(3)4;2*1-6-2-4-7(5-3-6)11(8,9)10/h10-11,14-15,17,19-20,23H,7-9,12-13,25H2,1-6H3;2*2-5H,1H3,(H,8,9,10)/t17-,19-,20-,23+;;/m1../s1
    2.1.3 InChI Key
    BXGKAGLZHGYAMW-TZYFFPFWSA-N
    2.1.4 Canonical SMILES
    CC1=CC=C(C=C1)S(=O)(=O)O.CC1=CC=C(C=C1)S(=O)(=O)O.CC(C)CC1CN2CCC3=CC(=C(C=C3C2CC1OC(=O)C(C(C)C)N)OC)OC
    2.1.5 Isomeric SMILES
    CC1=CC=C(C=C1)S(=O)(=O)O.CC1=CC=C(C=C1)S(=O)(=O)O.CC(C)C[C@@H]1CN2CCC3=CC(=C(C=C3[C@H]2C[C@H]1OC(=O)[C@H](C(C)C)N)OC)OC
    2.2 Other Identifiers
    2.2.1 UNII
    5SML1T733B
    2.3 Synonyms
    2.3.1 Depositor-Supplied Synonyms

    1. Valbenazine Ditosylate

    2. 1639208-54-0

    3. Valbenazine Tosilate

    4. Valbenazine (tosylate)

    5. Nbi-98854 Ditosylate

    6. Valbenazine Tosylate [usan]

    7. 5sml1t733b

    8. 1639208-54-0 (tosylayte)

    9. Valbenazine Tosilate (jan)

    10. Valbenazine Tosylate (usan)

    11. Valbenazine Tosilate [jan]

    12. (2r,3r,11br)-3-isobutyl-9,10-dimethoxy-1,3,4,6,7,11b-hexahydro-2h-pyrido[2,1-a]isoquinolin-2-yl L-valinate Di(4-methylbenzenesulfonate)

    13. L-valine, (2r,3r,11br)-1,3,4,6,7,11b-hexahydro-9,10-dimethoxy-3-(2-methylpropyl)-2h-benzo(a)quinolizin-2-yl Ester, 4-methylbenzenesulfonate (1:2)

    14. Ingrezza (tn)

    15. Nbi-98854 Tosylate

    16. Unii-5sml1t733b

    17. Valbenazine Tosylate (1:2)

    18. Chembl3707248

    19. Schembl18863051

    20. Valbenazine Tosylate [mi]

    21. Dtxsid201026308

    22. Hy-16771a

    23. S9500

    24. Valbenazine Tosilate [who-dd]

    25. Ccg-270445

    26. Valbenazine Tosylate [orange Book]

    27. Cs-0030913

    28. D10999

    29. Q27262815

    30. (2r,3r,11br)-9,10-dimethoxy-3-(2-methylpropyl)-1,3,4,6,7,11b-hexahydro-2h-benzo(a)quinolizin-2-yl L-valinate Bis(4-methylbenzenesulfonate)

    31. [(2r,3r,11br)-9,10-dimethoxy-3-(2-methylpropyl)-2,3,4,6,7,11b-hexahydro-1h-benzo[a]quinolizin-2-yl] (2s)-2-amino-3-methylbutanoate;4-methylbenzenesulfonic Acid

    2.4 Create Date
    2015-11-09
    3 Chemical and Physical Properties
    Molecular Weight 763.0 g/mol
    Molecular Formula C38H54N2O10S2
    Hydrogen Bond Donor Count3
    Hydrogen Bond Acceptor Count12
    Rotatable Bond Count10
    Exact Mass762.32198827 g/mol
    Monoisotopic Mass762.32198827 g/mol
    Topological Polar Surface Area200 Ų
    Heavy Atom Count52
    Formal Charge0
    Complexity776
    Isotope Atom Count0
    Defined Atom Stereocenter Count4
    Undefined Atom Stereocenter Count0
    Defined Bond Stereocenter Count0
    Undefined Bond Stereocenter Count0
    Covalently Bonded Unit Count3
    4 Drug and Medication Information
    4.1 Drug Information
    1 of 1  
    Drug NameINGREZZA
    Active IngredientVALBENAZINE TOSYLATE
    CompanyNEUROCRINE (Application Number: N209241. Patents: 8039627, 8357697)